Impact of palliative radiotherapy in patients with gynecologic malignancies on end-of-life outcomes

{"Objectives":[0],"We":[1],"investigated":[2],"the":[3,8,60,70,124,132],"use":[4],"of":[5,10,33,63,88,92,114,127,180],"radiotherapy":[6],"toward":[7],"end":[9],"life":[11,64],"(EOL)":[12],"in":[13,37,59,69,86,131,149,182,206],"patients":[14,215],"with":[15,82,112,123,138,143,159,194,219,230,240],"gynecologic":[16,34],"malignancies":[17],"and":[18,67,90,104,116,147,167,177,204,222,246],"its":[19],"relationship":[20],"to":[21,42],"established":[22],"EOL":[23,93,117,129,139,170,190,197,223,226,233,243],"healthcare":[24,244],"quality":[25],"indicators.":[26],"Methods":[27],"A":[28],"population-based,":[29],"retrospective":[30],"cohort":[31],"study":[32],"cancer":[35],"decedents":[36],"Ontario,":[38],"Canada":[39],"from":[40],"2006":[41],"2018":[43],"using":[44],"ICES-linked":[45],"administrative":[46],"health":[47],"care":[48,130,171,198],"data.":[49],"Results":[50],"Of":[51],"16,237":[52],"decedents,":[53],"26.7%":[54],"received":[55,216],"palliative":[56,236],"radiotherapy;":[57],"6.7%":[58],"last":[61],"31–90d":[62],"(\\"late":[65],"radiation\\"),":[66],"5.3%":[68],"final":[71,133],"30d":[72,134],"(\\"EOL":[73],"radiation\\").":[74],"The":[75],"most":[76],"common":[77],"site":[78],"was":[79,121,192,228,238],"pelvis":[80],"(44.2%),":[81],"single":[83],"fractions":[84],"used":[85],"13.4%":[87],"late":[89,115,154,221,235],"14.1%":[91],"regimens.":[94],"On":[95,151],"multivariable":[96,152],"analysis,":[97],"age":[98],"<":[99],"40":[100],"years,":[101],"non-ovarian":[102],"cancers,":[103],"stage":[105],"IV":[106],"disease":[107],"at":[108],"diagnosis":[109],"were":[110],"associated":[111,122,158,193,229,239],"receipt":[113],"radiation.":[118,224],"Late":[119],"radiation":[120,140,155,191,227,237],"lowest":[125],"rates":[126],"aggressive":[128,161,196,232,242],"(15.6%":[135],"vs.":[136,141],"27.7%":[137],"21.0%":[142],"neither),":[144],"including":[145],"hospitalization":[146],"death":[148,181,205],"hospital.":[150],"regression,":[153],"remained":[156],"significantly":[157],"less":[160,241],"(OR":[162,172,184,199,208],"0.80,":[163],"95%":[164,174,186,201,210],"CI":[165,175,187,202,211],"0.67–0.96)":[166],"more":[168,195,231,247],"supportive":[169,248],"1.24,":[173],"1.07–1.44),":[176],"lower":[178],"risk":[179],"hospital":[183,207],"0.86,":[185],"0.75–0.98),":[188],"while":[189],"1.41,":[200],"1.16–1.73)":[203],"1.71,":[209],"1.44–2.02).":[212],"Conclusion":[213],"Most":[214],"multifractionated":[217],"schedules":[218],"both":[220],"While":[225],"care,":[234],"utilization":[245],"care.":[249]}